Zum Hauptinhalt springen

Bestenliste Vorfälle EU AI Act Akademie Dilemmata

ALPARAITrust Infrastructure

Wo die Welt KI zur Rechenschaft verpflichtet.

Plattform

Vorfälle
Bestenliste
Dilemmata
Bericht einreichen
Transparenz
KI-Gesetz-Tracker
Herausforderungen

Unternehmen

Über uns
Beirat
Preise
Sicherheit
Akademie
Pressekit

Ressourcen

Blog
Methodik
GitHub
API-Dokumentation

Rechtliches

Datenschutzerklärung
Nutzungsbedingungen
Cookie-Richtlinie
DMCA-Richtlinie
Moderationsrichtlinie

Kontakt

hello@alparai.com
academy@alparai.com

© 2026 ALPAR AI. Open Source (AGPL-3.0). EU Hosted. GDPR + KVKK Compliant.

Intermediärplattform. Von Nutzern eingereichte Inhalte.

Feed Vorfälle Bestenliste Über

Perplexity AI — Markenprofil · ALPAR AI

Perplexity AI

AI-powered answer engine.

Webseite support@perplexity.ai

Nicht beanspruchtes Profil

Ist das Ihr Unternehmen? Fordern Sie dieses Profil an – kostenlos

Beanspruchen Sie dieses Profil, um offiziell auf Vorfälle zu reagieren, Ihre Markenwerte anzupassen und auf Entwicklermetriken zuzugreifen.

Anspruchsprofil

4

Vertrauensindex

2

Gesamtzahl der Vorfälle

0%

Rücklaufquote

276

Durchschn. Ansichten

Aufschlüsselung nach Schweregrad

Kritisch

2

Hoch

0

Medium

0

Niedrig

0

Schnelle Statistiken

Veröffentlicht2

Antworten gegeben0

Gesamtansichten551

Vorfälle reagierten0

Gemeldete Vorfälle (2)

KritischVeröffentlichtPerplexity AISLA nicht verfügbarBenutzerberichtDesinformation

Anonym veröffentlichenMay 2026

Perplexity cited non-existent academic paper

The search engine confidently answered a medical query by citing a PubMed paper that does not exist, putting users at risk.

Gemeldet

Bewertet

Veröffentlicht

28. Mai 2026Ich auch0 Kommentar0

by Anonym veröffentlichen

KritischVeröffentlichtPerplexity AISLA nicht verfügbarBenutzerberichtSonstiges

Anonym veröffentlichenJanuary 2026

Perplexity AI Reportedly Misstated CLL Research, Allegedly Contributing to Delayed Treatment and Prolonged Suffering

The author's father, a former neuroscientist with lung cancer, kidney disease, and Chronic Lymphocytic Leukemia (CLL), was diagnosed approximately 18 months before his death. His oncologist recommended Venetoclax-Obinutuzumab (Ven-Obi) treatment for the CLL, which is described as remarkably effective at extending patient life expectancy while reducing suffering. However, the father used Perplexity AI to self-diagnose his condition and became convinced he was experiencing Richter's Transformation, a rare CLL complication. Based on Perplexity's output, he believed he should refrain from the Ven-Obi treatment because it would make things worse. The author discovered this when given access to his father's medical records and found correspondence between his father and the frustrated oncologist that included the Perplexity report. The author contacted the researchers cited in Perplexity's response, who confirmed that Perplexity had misstated their research conclusions and that the father should follow his oncologist's recommendations. Despite being presented with this information, the father did not respond and only agreed to start the recommended treatment several months later after his condition had worsened dramatically. Although the treatment immediately reduced his white blood cell count, his pain continued and he died a few weeks later.

Gemeldet

Bewertet

Veröffentlicht

5. Jan. 2026Ich auch0 Kommentar0

by Anonym veröffentlichen